Bloomberg-Funded WHO Report Doubles Down Against Vaping


In what is almost certainly a preview of policies that will be urged at the fall meeting of the World Health Organization’s Framework Convention on Tobacco Control (FCTC), the WHO has issued a report on “new and emerging” tobacco and nicotine product use that encourages countries to adopt harsh anti-vaping and anti-harm reduction positions.

There is literally nothing new in the report. It’s the usual set of complaints and lies about vaping, and a reupping of the evergreen list of excuses for the WHO’s own feeble anti-smoking progress. Worldwide tobacco control efforts would be going swimmingly, the WHO says, except for those darn tobacco and “related” companies’ attempts to reverse the progress by encouraging uptake of non-combustible nicotine products like vapes (which, as usual, are called ENDS).

Vaping products contain nicotine, they explain, which may affect adolescent brain development. They’re marketed in thousands of flavors, which “can increase the palatability of the product and help them be targeted specifically at children and young adults.”

“Eighty-four countries still have no bans or regulations to address ENDS, leaving them particularly vulnerable to the activities of the tobacco and related industries,” says the report. Adolescents who vape, according to the WHO, are “more than twice as likely to later use conventional cigarettes.” (That has certainly not borne out with real live teenagers in the United States, where school-age smoking has fallen dramatically as teen vaping increased, and high schoolers smoked more in the only U.S. city with a total vape ban.)

The report was funded by Bloomberg Philanthropies, the foundation started by American billionaire and former New York City mayor Michael Bloomberg. Not coincidentally, Bloomberg has been appointed the “WHO Global Ambassador for Noncommunicable Diseases and Injuries”—a largely honorary title granted in recognition of the money he spends on tobacco control and other health policy efforts.

Bloomberg Philanthropies has spent billions funding the spread of prohibitionist dogma in countries around the world. In low- and middle-income countries (LMICs), Bloomberg-funded groups like the Campaign for Tobacco-Free Kids and The Union have urged outright bans on e-cigarettes, claiming those countries are incapable of properly implementing reasonable regulations.

In theory, the WHO and FCTC exist to create and promote health strategies demanded by member states. In reality, WHO tobacco policy goals and plans come from the top down. Bloomberg-sponsored Tobacco-Free Kids and its allies essentially run the WHO’s tobacco control operations as a subsidiary. It is those groups that will plot the recommendations the FCTC will present to member countries at November’s ninth Conference of the Parties (COP9) in the Netherlands.

With the promise of endless Bloomberg dollars, the WHO and FCTC aren’t even fearful of losing the support—and maybe funding—of the FCTC Secretariat’s largest donor: the government of the United Kingdom. A report issued by a UK Parliamentary study group earlier this year encouraged the British government to consider “dramatically scaling back” its funding of the WHO and FCTC if the international organizations don’t reconsider their opposition to vaping and tobacco harm reduction as an anti-smoking strategy.

But the WHO isn’t budging. “Nicotine is highly addictive. Electronic nicotine delivery systems are harmful, and must be better regulated,” said WHO Director-General Tedros Adhanom Ghebreyesus in a statement today.

Worldwide, smoking hasn’t declined since the launch of the FCTC nearly two decades ago. Indeed, the number of people who currently smoke (1.1 billion), and the number who die annually from smoking (eight million), has increased in that time.

It is in countries where low-risk nicotine products like vapes and snus are allowed that smoking rates have dropped the farthest and fastest. Only if you convince yourself that non-combustible nicotine products pose the same risks as cigarettes can vaping be considered the danger the WHO and its patron Bloomberg say it is.

“This report demonstrates that, sadly, the WHO still doesn’t understand the fundamental difference between addiction to tobacco smoking, which kills millions of people every year, and addiction to nicotine, which doesn’t,” said University of Nottingham Emeritus Professor of Epidemiology John Britton, who chaired the Royal College of Physicians’ Tobacco Advisory Group that produced that group’s landmark 2016 report on e-cigarettes.

“The WHO is also evidently still content with the hypocrisy of adopting a position which recommends the use of medicinal nicotine products to treat addiction to smoking, but advocates prohibition of consumer nicotine products which do the same thing, but better.”



Source link

Altria Group Is Getting Out Of The Wine Business


Tobacco giant Altria Group finalized an agreement to sell its wine enterprise for $1.2 billion.

RICHMOND — Earlier this month, Altria announced that it will be selling off its entire wine business, Ste. Michelle Wine Estates, to private equity firm Sycamore Partners for a whopping $1.2 billion. This decision comes as the American tobacco giant intends to move away from the manufacture and sale of cigarettes in an attempt to adopt smoking alternatives, including electronic cigarettes, oral products, and cannabis-based products.

According to both companies, Sycamore Partners is a private equity firm working in the food and retail distribution segments.

“We believe the Transaction is an important step in Altria’s value creation for shareholders and allows our management team greater focus on the pursuit of our Vision to responsibly transition adult smokers to a non-combustible future,” said Billy Gifford, Altria Group’s CEO, in a press release on July 9, 2021. “Ste. Michelle and its talented employees have built an outstanding portfolio of premium wine brands, and we wish them future success.”

“The Ste. Michelle leadership team and I look forward to working with the team at Sycamore Partners and believe we are well-positioned to drive the next phase of our growth,” said David Dearie, Ste. Michelle’s president and CEO said in the same release.

Ste. Michelle sells wines from estates in Washington state, Napa Valley in California, and other parts of the United States’ various wine-growing regions. Altria took control of Ste. Michelle when it bought a smokeless tobacco company for $10.4 billion in 2008.

Reuters reported at the beginning of July of 2021 that the deal will close in the second half of this fiscal year.

Unfortunately, Altria has fumbled in investments in the past few years.

Outside of its storied ownership of Ste. Michelle, Altria Group has likely lost more money on its nearly $13 billion investment in former e-cigarette unicorn Juul Labs.

Tobacco firm Philip Morris International also announced around the same time its investment into British bio-pharma company Vectura Group plc.

Altria Group Is Facing Antitrust Allegations From The FTC



Source link

Vapitaly 2021: Save the date


Vapitaly 2021 is going ahead!

Save the dates: Rome, 2-3 October

Vapitaly 2021 poster

Finally, some good news for the world of vaping, with the long-awaited Vapitaly 2021 event going ahead later this year!

Vapitaly 2021, held at the Fiera Roma Exhibition Center in Rome, will open its doors between Saturday October 2 and Sunday October 3, bringing together both the e-cig sector and the general public.

Particular attention will be paid to the safety of all participants, with nothing being left to chance.

The event will comply with national and regional COVID regulations, as well as the Exhibitions fairgrounds’ safety protocols, to allow the varied world of vaping to physically come together.

For over a year, the industry has been waiting to meet, share business experiences and build the human relationships that have been lacking so much in this time characterized by social distance.

To avoid the risk of crowding, the organizers have already planned for the use of space both internally and externally, as well as the possibility of limited admissions and limitations on tastings as required by law.

Thanks to careful planning, all participants will be able to live the unique experience of Vapitaly in complete safety, view the new products presented by national and international exhibitors, attend conferences and meet major stakeholders.

Exhibition spaces for Vapitaly 2021 are now available for purchase and we are inviting vaping companies to secure their place at Italy’s first physical vaping event after the lockdown.

Vapitaly allows you to witness a crucial moment in the restart of the industry and take part in an event that defines the strategies and trends of the entire market.

Manufacturers, retailers and importers will be reunited in the 11,000 sqm Hall One of the Fiera Roma Exhibition center, as well as outside areas and a dedicated B2B meeting space.

If you are interested in exhibiting at Vapitaly 2021 Rome, get in touch with the team either through email – [email protected] – or register through the Exhibitors portal which is accessible here.

Visitor registration will open in August; Remember to check Vapitaly’s website and subscribe to Vapitaly’s social media channels so you don’t miss any updates!

For more vaping events, head on over to our Events Directory.

The post Vapitaly 2021: Save the date appeared first on Vapouround.



Source link

Groups Oppose Philip Morris International Purchasing Pharma Company Vectura


Several public health and tobacco control groups are upset that Philip Morris International would even consider purchasing a pharmaceutical maker that develops inhaled treatments for respiratory diseases, including the COVID-19 infection.

NEW YORK CITY — Philip Morris International (PMI) announced recently that it would pursue purchasing a company specializing in the development of inhaled pharmaceutical treatments for respiratory diseases based in the United Kingdom.

The company, Vectura Group plc (based in Chippenham, Wiltshire, in England), agreed to the acquisition, which is valued at between $1 billion and $1.5 billion. PMI announced the intent to purchase Vectura in a press release indicating that it’s a part of its so-called Beyond Nicotine strategy and its move away from combustible cigarettes.

“The acquisition of Vectura, following the recently announced agreement to acquire Fertin Pharma, will position us to accelerate this journey by expanding our capabilities in innovative inhaled and oral product formulations in order to deliver long-term growth and returns,” said Jacek Olczak, PMI’s chief executive officer, in the mentioned press release.

For reference, Vaping Post reported on the acquisition of Fertin Pharma. Fertin develops pharmaceutical and nutraceutical products based on proprietary “oral and intra-oral delivery systems.” Fertin develops pills, lozenges, capsules, powders, and pouches.

He added: “The market for inhaled therapeutics is large and growing rapidly, with significant potential for expansion into new application areas. PMI has the commitment to science and the financial resources to empower Vectura’s skilled team to execute on an ambitious long-term vision. Together, PMI and Vectura can lead this global category, bringing benefits to patients, to consumers, to public health, and to society-at-large.”

Groups like the American Lung Association and the American Thoracic Society are concerned that the acquisition will undo years of work at Vectura Group. American Lung Association President and CEO Harold Wimmer and American Thoracic Society President Lynn Schnapp jointly released this statement about PMI’s attempt to purchase Vectura:

“The announcement that Philip Morris International (PMI) wants to acquire an inhaled medicine company is the latest reprehensible choice from a company that has profited from addicting users to its deadly products,” both said. “We are deeply concerned that PMI will use the inhalation services technologies developed by Vectura to make their tobacco products more addictive. We are also deeply troubled that this company could further profit from the disease their products have caused by now selling therapies to the same people who were sickened by smoking PMI cigarettes.”

“The American Lung Association and American Thoracic Society are disappointed that the board of Vectura, a maker of essential medical products, has approved this sale. We urge the shareholders of Vectura to reject the proposed sale. Failing share holder action, we urge the British government to use its oversight authority to intervene and stop the sale.”

Amid the outbreak of controversy, members of Parliament are likely to scrutinize the acquisition between PMI and Vectura. London Times reports that politicians in Parliament, including shadow secretaries dealing with business and biotechnology industry regulations, will further investigate the intentions behind the proposed buyout.

Philip Morris International Might Buy A Nicotine Gum Maker



Source link

Right To Switch Petition Sign Now and Save Vaping


As the World Health Organization gears up its bid for a global ban of all things vape, the Right To Switch petition is another way we the vapers can fight back.

At it’s COP9 meeting in November this year, the WHO is calling on world governments to outright ban vaping or at the very least ban flavours and bring in Draconian new laws.

right to switch pro vape petition

I’ve written at length about this, and recently featured the UK fightback campaign titled Back Vaping Saves Lives and the worldwide version Back Vaping Beat Smoking.

I urge you all to checkout those articles and sign up and together we can fight the power crazed ingnorant WHO.

OK…and breathe lol.

Organized by Voices4Vape, the Right To Switch petition has a simple premise:

Don’t let your right to choose alternatives to smoking be taken away! | #Right2Switch

Trust me, that’s what’s happened in many parts of the world and could be coming here in the UK – so it’s imperative we the vapers stand up and be counted.

The Right To Switch petition has 7 demands it wants the idiotic WHO to adhere too and they are:

  • 1) Stop lying to us and only provide guidance based on sound scientific facts, methodologies and principles.
  • 2) Regulate based on sound scientific facts that include stakeholder (consumer) participation as part of the decision making process.
  • 3) Don’t ignore the basic human right to harm reduction that is one of the WHO’s founding principles. “To serve public health at all times – to put people’s health interests first”.
  • 4) Stop interfering with the rights of adults to make informed choices regarding their health and well being.
  • 5) Don’t discriminate against smokers, or users of safer nicotine products, because they aren’t doing what you want them to do “We strive to make people feel safe, respected, empowered, fairly treated and duly recognized”
  • 6) Follow your own mandate of “We communicate openly with everyone and learn from one another”
  • 7) Don’t use the COVID-19 pandemic as an excuse to disregard our rights to choose alternatives. – “We are guided by the best available science, evidence and technical expertise, We continuously develop ourselves and innovate to respond to a changing world.”

who uk vape ban

IF the WHO gets its wish vaping as we know it will be gone for ever.

If you’re happy going back to smoking then do nothing.

If you want to keep your right to choose and have the Right To Switch – then please get involved!

A spokesman for the campaign urged vapers to sign adding:

All of us need to unite, as one, globally, for our voices to be heard loudly and clearly by those who would rather not listen.

As adults, we have every right to choose how we live our lives – the right to make informed choices for our health, including the choice to use safer nicotine products as an alternative to combustible tobacco.

A solution to the world’s smoking problem is already here, we need to make WHO FCTC HEAR US.

Indeed we do – and you know what to do:

Sign the Right To Switch petition now!



Source link

A Self-Help Smoking Cessation Intervention Designed for Dual Users 


A smoking cessation plan designed for dual users should include e-cigarette-specific strategies used by successful quitters.

Studies keep indicating that most vapers use e-cigarettes as intended, to quit smoking. However while switching, some users end up getting stuck in the dual use phase where they start vaping but also keep smoking.

Dual use of e-cigarettes and cigarettes tends to be discouraged by tobacco harm reduction experts and vaping advocates alike, as the whole point of vaping is cutting down on cigarettes. On the other hand, some argue that those who engage in dual use are still smoking less cigarettes, ie. reducing harm.

Two studies conducted in England in 2020, aimed to determine the relationship between dual use and smoking cessation success. The study titled, “Associations Between Dual Use of E-Cigarettes and Smoking Cessation: A Prospective Study of Smokers in England,” looked into this by analyzing the tobacco use behaviour within a cohort of 1,498 smokers in England.

The obtained results indicated that while dual use of e-cigarettes was not associated with reduced overall quit rates when compared to exclusive smoking or dual use of NRT, it was associated with a slightly higher quit attempt rate than exclusive smoking, but lower than dual use of NRT.

A program designed specifically for dual users

The second study, “Is Dual Use of Nicotine Products and Cigarettes Associated With Smoking Reduction and Cessation Behaviours? A Prospective Study in England,” analyzed once again the relationship between dual use and quitting activity (smoking reduction, quit attempts and use of evidence-based cessation aids).

A total of 413 current smokers taking part in the Smoking Toolkit Study, a representative survey of adults in England, were recruited, and provided data at baseline and at a 6-month follow-up. The compiled data indicated that dual users of e-cigarettes and cigarettes smoked fewer cigarettes per day at follow-up than at baseline, when compared to dual users of NRTs and cigarettes.

This study addressed this issue, by trying to develop a specific smoking cessation program that is tailor made for people who are stuck in this pattern. “Using formative data from in-depth interviews and employing learner verification, we adapted an existing, validated self-help smoking-cessation intervention (Stop Smoking for Good; SSFG) to create a targeted intervention for dual users, If You Vape: A Guide to Quitting Smoking (IYV).”

Strategies used by successful cigarette quitters

The research team looked into vape strategies used by successful quitters, suggesting they should be implemented. “Findings led to the inclusion of e-cigarette-specific strategies used by successful quitters such as gradually reducing nicotine levels, switching from tobacco flavor to alternative flavors, and limiting e-cigarette use to places one would normally smoke (i.e., not expanding use).”

“Suggestions from Phase II learner verification included broadening the visual appeal for a younger, more diverse demographic, expanding tips for quitting smoking via e-cigarettes, and expanding terminology for e-cigarette devices. Beginning with an efficacious self-help intervention, we used a systematic process to develop a version specifically for dual users.”

Irish Study Analysed E-Cig-Only and Dual Use Behaviours Amongst Teens



Source link

Philip Morris International Confirms Agreement to Acquire Fertin Pharma


PMI announced the acquisition for an enterprise value of DKK 5.1 billion (approximately USD 820 million1).

Media reports about the possible purchase started circulating last month. According to the Tobacco Reporter, Financial analysts from these reports said that the company (including its debt), could be valued at roughly $713.5 million.

A previous article by Vaping Post discussing the acquisition said that Fertin is the “world’s biggest contract development and manufacturing organization for nicotine chewing gum” and “also helps produce tablets, gum and lozenges used for pain medication, vitamins, cough treatments, and sleeping aids.”

Another step towards PMI’s goal of becoming a mostly smoke-free by 2025

Finally, PMI announced the acquisition for an enterprise value of DKK 5.1 billion (approximately USD 820 million1). This move supports the tobacco company’s goal of becoming a mostly smoke-free business by 2025, creating growth opportunities beyond tobacco.

“The acquisition of Fertin Pharma will be a significant step forward on our journey toward delivering a smoke-free future—enhancing our smoke-free portfolio, notably in modern oral, and accelerating our progress in beyond nicotine,” stated Jacek Olczak, Chief Executive Officer.

“Both PMI and Fertin share a commitment to science and consumer-centric innovations for better living, and I am delighted we have reached this agreement. Fertin’s diverse portfolio of technologies, evolving business mix, and world-class expertise will enrich our innovation pipeline and capabilities, providing speed and scale in oral delivery to support our 2025 goals of generating more than 50% of our net revenues from smoke-free products and at least USD 1 billion from products beyond nicotine.”

PMI Affiliate Opens Four IQOS Stores in The Philippines 



Source link

US: Vape Business Send Letter Urging FedEx to Reverse Delivery Ban


A nationwide measure, S 1253: “Preventing Online Sales of E-Cigarettes to Children Act,” passed the house last year and was signed into law by President Trump on the 27th of December 2020. The bill banned all shipments of vaping products by the US Postal Service, and would have forced all other postal delivery services (such as UPS, FedEx, or DHL) to check IDs and obtain signatures of adults at points of delivery.

To this effect, FedEx and the United Parcel Service (UPS) had already halted shipping vaping products from their end. However in April 2021, the U.S. Postal Service announced that it was delaying the ban. In an exclusive to Marijuana Business Daily, a spokesperson for the USPS said that more time is required “to review how to implement the changes ordered by Congress.”

Yet, FedEx and UPS did not reverse the ban from their end, with FedEx’s current rules preventing the shipment of vaping products from business to business or directly to vapers, many of whom live in remote areas were they might have difficulty obtaining them. This has prompted hundreds of small businesses to send a signed a letter organized by the AVA highlighting that the mail carrier’s delivery ban will prevent consumers from obtaining the products they’ve used to stop smoking.

Making safer alternatives unavailable is counterproductive

The letter is something of a last-ditch effort, a desperate ask. “If consumers are not able to access or afford these reduced-risk alternatives to cigarettes, they will be forced to turn back to combustible tobacco.”

“We rely on companies like FedEx to stock our store shelves and meet customer demand,” adds the letter. “Without the option to order vaping products at wholesale or ship their products to consumers, vape stores have seen their shipping options skyrocket in cost or evaporate entirely.

AVA president Greg Conley, highlighted that this measure is counterproductive. “FedEx is doing a great disservice to American small businesses and consumers,” he said in a press statement. “They are playing right into the hands of Big Tobacco, which directly benefits from policies that make it more expensive for adult smokers to switch. Not only are vaping products legal and regulated by the Food and Drug Administration, but they are saving lives by keeping people off combustible cigarettes.”

Read Further: Filter

A Ban on Vape Mail Would Also Impact The Cannabis Industry

 



Source link

Press Release: Geekvape and Paris Saint-Germain Announce Official Partnership


On July 23rd (GMT+8), before the new Ligue 1 season kicks off, Geekvape, the world-renowned vape brand, and Paris Saint-Germain, the European football powerhouse, announced together the official partnership starting from the 2021-2022 season. It is the first time in history that a football giant partners with a vape brand. Both sides will work together on campaigns, TV commercials, and co-branded products in authorized countries. Geekvape fans around the world will also have the opportunity to see the team in real life.

“Geekvape has always followed a brand concept of ‘Love of Life’ and building an excellent life experience, while Paris Saint-Germain is known for playing elegant football” said Allen Yang, the CEO of Geekvape Technology. “In their own sectors, Geekvape and Paris Saint-Germain are sharing the same passion for ‘Excellence’ and ‘Elegance.’ And based on this common idea, we have come together today. Six years after its creation, Geekvape has grown into an international brand serving millions of users around the globe. The partnership with Paris Saint-Germain is an essential step in its brand strategic upgrade and will, at the same time, attract more users to feel the positive energy brought by football through Paris Saint-Germain’s football magic.”

Marc Armstrong, Paris Saint-Germain’s Chief Partnerships Officer, said: “We are delighted to welcome Geekvape to the Paris Saint-Germain family. Geekvape is an innovative Chinese brand with worldwide ambition. We both share the same determination to ally excellence and elegance. We are looking forward to working together to develop creative campaigns.”

Geekvape, founded in 2015, is an innovative technology company headquartered in Shenzhen, China. Geekvape’s mission is to build a creative life experience and provide a reliable product experience. For a long time, Geekvape continuously creates and thinks differently, aiming to positively impact society.

About Paris Saint-Germain

Paris Saint-Germain football club was created in 1970 and celebrated its 50th anniversary in 2020. Since QSI’s purchase of the club in 2011, it has transformed to become one of the top football clubs and global sports brands in the world. The club has since then won 27 trophies in only ten years, 43 in its history, becoming the most successful football club in France. Paris Saint-Germain has attracted many great players including Ronaldinho, Beckham, Ibrahimovic, and currently Neymar Jr and Mbappé, both ranked amongst the top players in the world. The international popularity of the club never stops growing. It is now one of the most followed clubs in the world, expanding from zero to a community over 100 million social media followers in just ten years. The pioneering sports club which now includes men’s football, women’s football, handball, and judo, added esports in 2016. Giving back to the community is fundamental to the club which has drastically increased the capacity of its foundation to develop large programs for underprivileged youths.



Source link

UK: NHS May be Giving Pregnant Women £400 Vouchers to Quit Smoking


Research suggests that for every 1,000 pregnant women offered vouchers, 177 would stop smoking.

Research, says the guidance, suggests that for every 1,000 pregnant women offered vouchers, 177 would stop smoking. “Evidence from the UK showed that schemes in which a maximum of around £400 could be gained in vouchers staggered over time (with reductions for each relapse made) were effective and cost effective.”

The National Institute for Health and Care Excellence (Nice) and Public Health England said evidence shows that offering financial incentives to help pregnant women stop smoking is “both effective and cost effective.”

Their guidance, which is open to consultation, said women should undergo biochemical tests to prove they have stopped smoking before receiving the vouchers. However, they added, if the testing proves too difficult due to any current COVID-19-related restrictions, the vouchers should be given anyway.

The document also highlighted that healthcare staff should give clear and up-to-date information regarding e-cigarettes to anyone interested in using them to quit smoking, whilst mentioning that their long-term health effects are still uncertain.

Stop Smoking Services Staff opinions about vapes

In the UK e-cigarettes remain the most popular smoking cessation aid to date, however, opinions about vaping during pregnancy tend to vary. A recent local study aimed to gauge the general perception of English Stop Smoking Services (SSS) towards vaping in order to quit smoking amongst pregnant women.

Most SSS managers said they support the use of e-cigarettes amongst pregnant women who already vaped prior to the pregnancy. However they added, they would not recommend vaping to those who were still smoking and not using e-cigarettes. A total of 8.3% of the managers said they were likely/very likely to advise using e-cigarettes, while 56.9% of SSS were unlikely/very unlikely to advise using them.

Read Further: Chronicle Live

UK: NHS Launches ‘Don’t Wait’ Quit Smoking Campaign 



Source link